COMMUNIQUÉS West-GlobeNewswire

-
Evaxion announces closing of $10.8 million public offering
31/01/2025 -
GH Research to Provide Update on Phase 2b Trial with GH001 in TRD
31/01/2025 -
Oculis updates share capital for its existing at-the-market offering program
31/01/2025 -
Bavarian Nordic – Completion of Share Buy-Back Program
31/01/2025 -
Women in Science: Breaking Barriers with HNL Lab Medicine
31/01/2025 -
EssilorLuxottica: Full-Year 2024 Results Conference Call Invitation
31/01/2025 -
EssilorLuxottica: Full-Year 2024 Results Conference Call Invitation
31/01/2025 -
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference
31/01/2025 -
Roche receives FDA approval for the first companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for ENHERTU
31/01/2025 -
Correction: GUERBET : Financial agenda for 2025
31/01/2025 -
Correction: GUERBET : Calendrier financier de l'exercice 2025
31/01/2025 -
Heron’s Key Announces Exciting Expansion with Upcoming Pre-Sales
31/01/2025 -
TerrAscend Announces Preliminary Fourth Quarter 2024 Financial Results and Schedules Earnings Conference Call
31/01/2025 -
Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade
31/01/2025 -
Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
31/01/2025 -
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025
31/01/2025 -
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results
31/01/2025 -
ARCPOINT ANNOUNCES C$800,000 NON-BROKERED PRIVATE PLACEMENT
31/01/2025 -
Outlook Therapeutics® Appoints Faisal G. Sukhtian as Chairman of the Board of Directors
31/01/2025
Pages